01 4AstraZeneca Canada Inc.
01 22402894
02 22568391
01 4Saxagliptin Hydrochloride
01 4Tablet
01 22021-03-05
02 22025-05-26
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Brand Name : ONGLYZA
Patent Number : 2568391
Filing Date : 2005-05-26
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Brand Name : ONGLYZA
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Brand Name : ONGLYZA
Patent Number : 2568391
Filing Date : 2005-05-26
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Brand Name : ONGLYZA
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
LOOKING FOR A SUPPLIER?